Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2004

01-07-2004 | Original Articles

Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFβ1, bFGF, and EGF

Authors: Hidehisa Horiguchi, Long Jin, Katharina H. Ruebel, Bernd W. Scheithauer, Ricardo V. Lloyd, MD, PhD.

Published in: Endocrine | Issue 2/2004

Login to get access
Metadata
Title
Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFβ1, bFGF, and EGF
Authors
Hidehisa Horiguchi
Long Jin
Katharina H. Ruebel
Bernd W. Scheithauer
Ricardo V. Lloyd, MD, PhD.
Publication date
01-07-2004
Publisher
Humana Press
Published in
Endocrine / Issue 2/2004
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:24:2:141

Other articles of this Issue 2/2004

Endocrine 2/2004 Go to the issue

Original Articles

Atorvastatin enhances bone density in ovariectomized rats given 17β-estradiol or human parathyroid hormone(1–34)

Original Articles

Serotonin may alter the pattern of gonadotropin-induced progesterone release of human granulosa cells in superfusion system

Original Articles

Nature of changes in adrenocortical function in chronic hyperleptinemic female rats

Original Articles

Heparin increases prolactin and modifies the effects of FGF-2 upon prolactin accumulation in pituitary primary cultures

Original Articles

Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit

Original Articles

The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits